The effect of ranolazine on maintaining sinus rhythm in patients with resistant atrial fibrillation

Autor: Murdock, David K, Overton, Naomi, Kersten, Mary, Kaliebe, Jeff, Devecchi, Fausto

Publikováno v: Indian Pacing and Electrophysiology Journal, Vol 8, Iss 3, Pp 175-181 (2008)
Indian Pacing and Electrophysiology Journal

Background: Atrial fibrillation (AF) may arise out of anomalous impulse activity at atrial venous junctions. Triggered activity may be a source of abnormal impulse activity. Ranolazine is an anti-anginal agent, which inhibits normal and abnormal late

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::e33532dad40bfeb9e5b08821e677e76e
http://www.ipej.org/0803/murdock.htm

The use of oral ranolazine to convert new or paroxysmal atrial fibrillation: a review of experience with implications for possible "pill in the pocket" approach to atrial fibrillation.

Autor: Murdock DK; The Aspirus Heart and Vascular Institute, Cardiovascular Associates of Northern Wisconsin and The CaRE Foundation, Wausau Wisconsin 54403, USA. dkmurdock@charter.net, Kersten M, Kaliebe J, Larrain G

Publikováno v: Indian pacing and electrophysiology journal [Indian Pacing Electrophysiol J] 2009 Sep 01; Vol. 9 (5), pp. 260-7. Date of Electronic Publication: 2009 Sep 01.